Woodline Partners’s BridgeBio Oncology Therapeutics, Inc. Common Stock BBOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.1M Hold
103,247
0.01% 796
2025
Q1
$1.17M Hold
103,247
0.01% 750
2024
Q4
$1.08M Hold
103,247
0.01% 744
2024
Q3
$1.08M Hold
103,247
0.01% 503
2024
Q2
$1.06M Sell
103,247
-3,458
-3% -$35.3K 0.01% 456
2024
Q1
$1.11M Buy
+106,705
New +$1.11M 0.01% 453